AMBRA1 and loricrin as a test to identify low-risk early-stage melanoma

Br J Dermatol. 2024 Mar 15;190(4):e46. doi: 10.1093/bjd/ljae078.NO ABSTRACTPMID:38488655 | DOI:10.1093/bjd/ljae078
Source: The British Journal of Dermatology - Category: Dermatology Source Type: research